Kidney (urinary) syndromes
Introduction to Kidney (Urinary) Syndromes and Urinalysis
Kidney (urinary) syndromes refer to constellations of clinical signs, symptoms, and laboratory findings that suggest dysfunction or disease affecting the kidneys and/or the urinary tract. A cornerstone in the evaluation of these syndromes is the **urinalysis**, which includes macroscopic examination, chemical analysis (dipstick), and microscopic examination of the urine sediment. The presence of certain elements in the urine sediment, such as proteins, cells, casts, or pigments, can provide valuable clues to the underlying pathology.
This section will discuss the clinical and diagnostic value of various abnormal findings in the urine, often grouped under specific "urinary syndromes" or abnormal "urias." Understanding these can help pinpoint the nature and location of potential problems within the urinary system or reflect systemic diseases impacting renal function.
Overview Table of Major Urinary Syndromes and Sediment Findings
The following table summarizes common abnormal findings in urine (often termed "syndromes" ending in "-uria"), their primary causes, and associated pathological conditions. Note that IDs within the table correspond to internal links for more detailed information on specific conditions if available elsewhere.
Syndrome / Finding |
Primary Cause / Mechanism |
Common Pathological Conditions |
---|---|---|
Proteinuria (Protein in Urine) |
Increased permeability of glomerular capillaries (glomerular proteinuria). | Fever, intoxication, strenuous physical exertion, hypothermia (often transient). |
Slowing of renal blood flow, increased permeability of glomerular capillaries (stagnant/ischemic proteinuria). | Impaired renal hemodynamics (e.g., congestive heart failure, leading to decreased urine volume with high specific gravity), toxic and medicinal nephropathy, prolonged constipation or severe diarrhea, prolonged sun exposure (insolation). | |
Focal renal membrane defect, often related to posture (orthostatic proteinuria). | Orthostatic (postural) proteinuria, typically benign in adolescents. | |
Increased permeability of the glomerular membrane (glomerular proteinuria). Decreased tubular reabsorption of normally filtered proteins (tubular proteinuria). | Acute and chronic glomerulonephritis (especially with nephrotic syndrome), pyelonephritis, amyloidosis, renal tuberculosis, kidney cancer, renal abscess, polycystic kidney disease, echinococcosis of the kidney, kidney stones. | |
Paraproteinuria (Overflow Proteinuria) |
Filtration of abnormal, low molecular weight (MM) monoclonal proteins (e.g., immunoglobulin light chains - Bence Jones proteins) synthesized by tumor (myeloma) cells, overwhelming tubular reabsorption. | Multiple myeloma, Waldenström's macroglobulinemia, other monoclonal gammopathies. |
Myoglobinuria (Myoglobin in Urine) |
Filtration of low molecular mass myoglobin due to necrosis (damage/breakdown) of muscle tissue (rhabdomyolysis). | Myopathies, myocardial infarction (though less common for myoglobinuria than troponin elevation), crush syndrome, severe trauma, burns, extreme exertion, certain toxins/drugs. |
Hemoglobinuria (and Hemosiderinuria - Iron in Urine) |
Filtration of free hemoglobin (a protein with low molecular mass) during significant intravascular hemolysis of erythrocytes, or destruction of erythrocytes by parasites. Hemosiderinuria results from renal tubular processing of filtered hemoglobin over time. | Hemolytic anemias (autoimmune, drug-induced, mechanical), malaria, severe burns, incompatible blood transfusion reactions, poisoning (e.g., snake venom, certain chemicals), severe infectious diseases (sepsis, scarlet fever). |
Hematuria (Red Blood Cells in Urine) |
Damage to the renal filter (increased permeability of the glomerular membrane) due to destructive or inflammatory processes (glomerular hematuria). | Acute and chronic glomerulonephritis, IgA nephropathy, lupus nephritis, amyloidosis, nephrosclerosis, kidney cancer, nephrolithiasis (kidney stones), renal tuberculosis, renal vascular diseases (angiosclerosis). |
Increased vascular permeability due to hypocoagulation or bleeding disorders (prerenal hematuria). | Congenital and acquired coagulopathies (e.g., hemophilia, von Willebrand disease), hemorrhagic diathesis, hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease), severe liver damage (impaired clotting factor synthesis), collagen vascular diseases with vasculitis. | |
Glomerular membrane instability or defects. | ||
Damage to the interstitial tissue of the kidneys, epithelium of the tubules, or renal intravascular coagulation. | ||
Direct hemorrhage, trauma, or rupture of renal vessels or vessels in the lower urinary tract (postrenal hematuria). | Urinary tract stones, tumors (bladder, ureter, prostate), infections (cystitis, urethritis), trauma, benign prostatic hyperplasia. | |
Pyuria (Leukocyturia - White Blood Cells in Urine): |
||
Neutrophilic Pyuria (Most Common) | Infectious and inflammatory lesions of the kidneys or urinary tract. | Cystitis, urethritis, prostatitis, pyelonephritis, renal tuberculosis, kidney cancer (can cause inflammation), renal abscess, urolithiasis with infection. |
Lymphocyturia | Chronic glomerulonephritis, lupus nephritis, late stage of chronic lymphocytic leukemia, viral infections, transplant rejection, interstitial nephritis. | |
Eosinophiluria | Allergic interstitial nephritis (often drug-induced), chronic pyelonephritis (especially tuberculous), some forms of cystitis, allergic urethritis, parasitic infections of urinary tract. | |
Cylindruria (Urine Casts): |
||
Hyaline Casts | Coagulation of Tamm-Horsfall protein in the renal tubules, often with concentrated/acidic urine or proteinuria. | Normal (few), dehydration, fever, strenuous exercise, diuretic use, proteinuria of any genesis (e.g., in toxicosis, sepsis, jaundice, influenza and other infectious diseases). |
Granular Casts | Degeneration of cellular casts or aggregation of plasma proteins within tubules. | Acute glomerulonephritis, nephrotic syndrome, chronic kidney disease, pyelonephritis, acute tubular necrosis. |
Waxy Casts | Prolonged stasis and degeneration of hyaline/granular casts in dilated tubules, often with increased urine viscosity, hemodynamic disturbances, slow blood flow, dehydration, low pH, presence of bile acids, mucoproteins. Other cast types depend on deposition of hemoglobin, bilirubin, epithelial cells, salts on the protein matrix. | Severe/advanced chronic kidney disease, end-stage renal disease, acute glomerulonephritis, nephrotic form of chronic nephritis, pyelonephritis, renal tuberculosis, kidney cancer, nephrolithiasis, diabetic nephropathy, lupus erythematosus, osteomyelitis, paraproteinemic nephropathy, lipoid nephrosis, amyloidosis of the kidney. |
Erythrocyte (RBC) Casts, Hemoglobin Casts | Hemorrhage within the renal parenchyma (glomeruli or tubules). | Glomerulonephritis, renal vasculitis, renal embolism or infarction. |
Epitheliuria (Epithelial Cells in Urine): |
||
Transitional Epithelial Cells | Exfoliation due to inflammatory processes of the mucous membranes of the urinary tract (renal pelvis, ureters, bladder, proximal urethra). | Acute and chronic cystitis, pyelitis, infectious diseases, medication effects, urethritis, intoxications, kidney stone disease, catheterization. |
Squamous Epithelial Cells | Exfoliated from the skin of external genital organs (female) and the distal part of the urethra (male and female). | Usually represent contamination if numerous; small numbers normal. |
Exfoliates in layers or atypical forms. | Leukoplakia of the bladder, certain types of bladder cancer (rarely diagnosed this way). | |
Renal Tubular Epithelial (RTE) Cells | Degenerative lesions or necrosis of the renal tubules. Fatty degeneration of RTE cells. | Acute tubular necrosis (ATN), nephrotic form of chronic glomerulonephritis, lipoid nephrosis, acute renal failure, certain viral infections, transplant rejection, heavy metal poisoning. |
Glucosuria (Glucose in Urine) |
Insulin deficiency or resistance, leading to decreased glucose consumption in tissues and impaired glycogen formation (hyperglycemic glucosuria). | Diabetes mellitus (Type 1, Type 2, Gestational), acute and chronic pancreatitis (can impair insulin production). |
Excessive intake of carbohydrates (alimentary glucosuria). | Transient glucosuria after a very high carbohydrate meal. | |
Enhanced liver glycogenolysis or gluconeogenesis (stress hyperglycemia). | Central (nervous system) origin glucosuria (e.g., TBI, stroke, seizures, severe stress). | |
Hormonal imbalances leading to hyperglycemia. | Hyperthyroidism, acromegaly, Cushing's syndrome/disease, pheochromocytoma. | |
Liver dysfunction affecting glucose homeostasis. | Hepatic glucosuria (rare, in severe liver disease). | |
Decreased glomerular filtration of glucose (can mask glucosuria despite hyperglycemia if GFR very low). | Development of glomerulosclerosis and advanced kidney disease (kidney wrinkling). | |
Impaired reabsorption of glucose in the renal tubules due to damage to proximal tubules or insufficiency of glucose transport systems (renal glucosuria). | Primary (familial) renal glucosuria (with normal blood glucose), secondary renal glucosuria with chronic nephritis, nephrosis, acute renal failure, Fanconi syndrome, pregnancy (physiological). | |
Ketonuria (Acetone, Acetoacetic acid, Beta-hydroxybutyric acid in Urine) |
Excessive formation (increased ketogenesis) due to insulin deficiency and/or decreased breakdown of ketone bodies (impaired ketolysis). | Diabetes mellitus (especially Diabetic Ketoacidosis - DKA). |
Enhanced ketogenesis due to carbohydrate deprivation. | Starvation, prolonged fasting, ketogenic diets, persistent vomiting/diarrhea (e.g., toxicosis, prolonged gastrointestinal upset, dysentery). | |
Enhanced protein breakdown and fat metabolism. | High-fat/ketogenic diets, postoperative catabolic states, severe febrile illnesses. | |
Impaired ketolysis (ketone utilization). | Glycogen storage diseases (e.g., Von Gierke's). | |
Increased metabolic rate and glucose consumption. | Thyrotoxicosis (hyperthyroidism). | |
Significant loss of carbohydrates from the body. | Severe renal glucosuria (rarely causes significant ketosis alone). | |
Increased carbohydrate utilization and fat mobilization due to hormonal excess. | Acromegaly (excessive growth hormone), Cushing's syndrome/disease (increased glucocorticoids). | |
Severe irritation and agitation of the central nervous system. | Traumatic brain injury, subarachnoid hemorrhage, severe stress. | |
Indicanuria (Indican in Urine) |
Increased protein breakdown in tissues or intense decay of protein substances (tryptophan) in the intestine by bacteria, leading to indole formation, absorption, and hepatic conversion to indican for urinary excretion. | Malignant tumors with cachexia, empyema, bronchiectasis, lung abscess, intestinal obstruction/stenosis, malabsorption syndromes, tuberculous peritonitis, typhus, chronic constipation, severe dyspepsia, uremia. |
Nitrituria (Nitrites in Urine) |
Conversion of dietary nitrates in urine to nitrites by nitrate-reducing bacteria (e.g., *E. coli*, *Klebsiella*, *Proteus*). Note: Gonococci, streptococci, and tubercle bacilli do not typically form nitrites. | Bacteriuria (Urinary Tract Infection - UTI). Historically mentioned with acute yellow atrophy of the liver, but primarily a UTI marker. |
Lipiduria (Lipids, Leucine, Tyrosine, Cholesterol in Urine) |
Fatty degeneration of renal tubular epithelial cells, leading to shedding of lipid-laden cells or free lipid droplets into urine. Increased glomerular permeability to lipoproteins. | Nephrotic syndrome of various origins (e.g., minimal change disease, FSGS, membranous nephropathy), lipoid nephrosis (historical term for minimal change disease), severe diabetic nephropathy. |
Mucus (often in the form of cylindroids - mucus casts) |
Excessive production of mucoprotein (like Tamm-Horsfall protein) by cells of the renal tubules or mucus secretion by the epithelium of the lower urinary tract. | Inflammatory processes in the renal tubules or lower urinary tract (urethritis, cystitis). Small amounts normal, especially in females due to vaginal contamination. |
Bilirubinuria (Bilirubin in Urine) |
Impairment in the hepatocyte's process of conjugating bilirubin and/or excreting conjugated bilirubin into bile (cholestasis). Only conjugated (direct) bilirubin is water-soluble and can appear in urine. | Parenchymal liver disease (e.g., viral hepatitis, toxic-allergic hepatitis, cirrhosis, liver poisoning from cytostatic therapy). Medicinal jaundice. Inherited disorders of bilirubin metabolism (e.g., Dubin-Johnson syndrome, Rotor syndrome). |
Intrahepatic or extrahepatic cholestasis (impaired bile outflow). | Cholelithiasis (gallstones obstructing bile ducts), tumors compressing bile ducts (e.g., pancreatic cancer, cholangiocarcinoma), primary biliary cholangitis. | |
Urobilinuria (Increased Urobilinogen in Urine) |
Loss of the ability of affected hepatocytes to re-process urobilinogen absorbed from the intestine via enterohepatic circulation, or increased production of bilirubin (e.g., hemolysis). | Liver disease (hepatitis of various origins, cirrhosis), hemolytic anemias (increased bilirubin turnover), resorption of large hematomas. |
Porphyrinuria (Porphyrins in Urine) |
Inherited enzymatic defects in the synthesis of porphyrins in the liver (Hepatic Porphyrias). | Porphyrias: Acute Intermittent Porphyria (AIP - increased ALA, PBG, uroporphyrin), Variegate Porphyria (VP - increased ALA, PBG during attacks; copro- & protoporphyrin in feces), Hereditary Coproporphyria (HCP - increased ALA, PBG during attacks; coproporphyrin in urine/feces), Porphyria Cutanea Tarda (PCT - increased uroporphyrin, hepta/hexa/penta-carboxyl porphyrins). (Note: "protocoproporphyria" and "urocoproporphyria" are not standard terms, likely referring to patterns in VP/HCP/PCT). |
Inherited enzymatic defects in porphyrin synthesis in erythroblasts of the bone marrow (Erythropoietic Porphyrias). | Erythropoietic Protoporphyria (EPP - increased protoporphyrin in RBCs/feces), Congenital Erythropoietic Porphyria (Günther's disease - increased uroporphyrin I, coproporphyrin I in urine/RBCs). | |
Symptomatic (acquired) disorders of porphyrin synthesis due to various pathologies or exposures. | Lead poisoning, other heavy metal poisoning, severe liver disease (hepatitis, cirrhosis), alcoholism, certain neoplasms, radiation exposure, cytostatic therapy, myoglobinuria (can affect renal handling of other substances), significant hemolysis. |
Clinical Significance and Further Evaluation
The detection of abnormal elements or syndromes in the urine is a critical first step in diagnosing a wide range of conditions. Each finding, whether it's proteinuria, hematuria, casts, or specific pigments, points towards potential dysfunction in the kidneys, urinary tract, or systemic processes affecting these organs. It is essential that these laboratory findings are interpreted in the context of the patient's overall clinical picture, including symptoms, medical history, and physical examination.
Further evaluation often involves more specific blood tests, advanced urine analyses (e.g., 24-hour collections, protein electrophoresis), imaging studies (ultrasound, CT, MRI), and sometimes invasive procedures like cystoscopy or kidney biopsy to reach a definitive diagnosis and guide appropriate management.
When to Consult a Specialist
Consultation with a primary care physician, urologist, or nephrologist is warranted when urinalysis reveals significant abnormalities such as persistent proteinuria, hematuria, cellular casts, or other pathological findings. Symptoms such as changes in urine color or appearance, pain during urination, flank pain, unexplained swelling, or signs of systemic illness also necessitate medical evaluation. Early diagnosis and management of underlying conditions identified through urinalysis can prevent progression of kidney disease and other serious health consequences.
References
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 23rd ed. Elsevier; 2017. Chapter 28: Basic Examination of Urine.
- Brunzel NA. Fundamentals of Urine & Body Fluid Analysis. 4th ed. Saunders; 2018.
- Fogazzi GB. The Urinary Sediment: An Integrated View. 3rd ed. Elsevier Masson; 2010.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3(1):1–150. (Context for proteinuria, hematuria, etc.)
- Rose BD, Rennke HG. Renal Pathophysiology: The Essentials. Williams & Wilkins; 1994.
- Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of Heme Biosynthesis: X-Linked Sideroblastic Anemia and the Porphyrias. In: Valle D, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA, eds. The Online Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill; 2019. (Context for porphyrinuria)
- Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab Res Rev. 1999 Nov-Dec;15(6):412-26. (Context for ketonuria)
- Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. 2000 Aug;11(8):1553-61. (Context for myoglobinuria)
See also
- Benign Prostatic Hyperplasia (BPH)
- Cystitis (Bladder Infection)
- Hydrocele (Testicular Fluid Collection)
- Kidney Stones (Urolithiasis)
- Kidney (Urinary) Syndromes & Urinalysis Findings
- Bilirubinuria and Urobilinogenuria
- Cylindruria (Casts in Urine)
- Glucosuria (Glucose in Urine)
- Hematuria (Blood in Urine)
- Hemoglobinuria (Hemoglobin in Urine)
- Ketonuria (Ketone Bodies in Urine)
- Myoglobinuria (Myoglobin in Urine)
- Proteinuria (Protein in Urine)
- Porphyrinuria (Porphyrins in Urine) & Porphyria
- Pyuria (Leukocyturia - WBCs in Urine)
- Orchitis & Epididymo-orchitis (Testicular Inflammation)
- Prostatitis (Prostate Gland Inflammation)
- Pyelonephritis (Kidney Infection)
- Hydronephrosis & Pyonephrosis
- Varicocele (Enlargement of Spermatic Cord Veins)
- Vesiculitis (Seminal Vesicle Inflammation)